Searching for Problems and Ignoring Solutions

 

I took statistics in college, and we studied it in medical school, but for some reason it didn’t really affect me.  Then, later in my career, I gradually came to the realization that many of the decisions I was making for my patients were based on guesswork.  Educated guesswork.  But still, I was mostly guessing.  That is a terrifying realization for a physician to make.  Although in my view, it’s more terrifying when a physician doesn’t realize it.

Anyway, at that point, I started studying statistics in earnest.  I’m good at math, and had always excelled at calculus and so on in school.  But I slowly reached the conclusion that statistics isn’t really math.  At least, not in my view.  It’s a way of looking at the world.  In fact, the world doesn’t make much sense, until you understand statistics.  At that point, things become a little clearer (or, perhaps, a bit less unclear), and decision making becomes simpler.  Again – the use of statistics does not make things more complex.  It makes things simpler.

I’ve given hundreds of speeches to doctors’ groups all over the country (mostly about heart disease), and I spend a lot of time on statistics.  The number one complaint I get on my reviews is, “I’m not a mathematician!  I’m a doctor!  Talk about medicine, not math!”  I respond simply that medicine is complex, and it’s virtually impossible to understand if you don’t understand statistics.  Math is simply the language we use to precisely describe complicated things.  I teach about math, because I don’t know how else to explain how heart disease works.  But after having explained my point to countless doctors, and countless patients, I’ve noticed a few trends about how people look at complex problems.  Perhaps you’ll recognize these trends, based on your experiences:

I think that in general, most doctors order way too many tests.  They don’t necessarily understand exactly how those tests are done, or what they measure exactly, or what to do with the results.  But if they think someone has heart disease, they just start checking every box on the “Cardiovascular” panel.  I explained part of my concern about this in a previous post:

A couple years ago I was giving a lecture to a group of Cardiologists about advanced cardiovascular testing, and someone asked if I used a certain lab test.  I answered, no, that I found it unhelpful.  He protested that it was an accurate test.  I agreed, but replied, “To me, it’s like an Obama sticker on a Prius.  It may be accurate, but it doesn’t add any information that you didn’t already know.”

So I spend a lot of time trying to get doctors to think backwards, sort of.  What can be done if the person has this disease?  What tests will help you determine your course of action?  What tests are unhelpful, and therefore potentially misleading?  This is a big, complicated topic well beyond the scope of this post.  But my point is that lots of very intelligent physicians struggle with relatively straightforward data analysis.  And they do this for a living.

Imagine those with no background in math.

I’ve noticed that a patient’s inclination to treat a disease is often inversely proportional to their inclination to collect data about that disease.  And I think that perhaps that dichotomy might help explain many of our social problems today.  Let me try to explain.  See if you agree with my premise…

“Susan” had dinner at her club last month with a patient of mine, who happens to be a retired cardiovascular surgeon.  He went on at some length about how impressed he was with my efforts to approach heart disease in a rational, evidence-based manner.

Susan is very fit and focused on her health, because everybody in her family dies young of heart disease.  Her total cholesterol is always over 300 despite her best efforts.  She refuses to take statins or other ‘cholesterol drugs,’ but understands that she has a problem.  She was so impressed by what her friend said that she paid her money and joined my practice.  Our first visit was fascinating:

Susan:  “I really look forward to working with you.  Dr. Smith said you’re really good at heart disease.”

Me:  “Thanks!  I do the best I can.  How can I help you?”

Susan:  “I have really high cholesterol and a lousy family history.  But I don’t want to put a bunch of chemicals in my body, and all my previous physicians have tried to put me on a bunch of drugs.  I’ll be interested to hear your advice.”

Me:  “Sure.  Do you have any of your previous labs?”

Susan:  “Here’s the last set of labs from my previous doc.”
* hands me a big stack of papers *

Me:  * starts paging through every lab test I’ve ever heard of, and some that I hadn’t… *
“Wow.”

Susan:  “Wow?  What do you mean?”

I’m not sure what to say here.  Either her previous physician had no idea what she was doing, or she was trying to show off by ordering lots of exotic tests.  I suppose it doesn’t matter which one is true.  I’m trying not to step on toes, so I ask, “So, um, what did your previous doc say about all this?”

Susan:  “She tried to put me on a statin.  But I’ve read that statins are bad for you.”

Me:  “I can believe that.”

Susan:  “You believe that statins are bad for you?”

Me:  “No.  I can believe that you read that.”

Susan:  “What do you mean?”

Me:  “I mean that if your previous doc had read your family history, and had looked at these labs, and decided not to treat, that I would call that doctor on the phone and ask what on earth she was thinking.”

Susan:  “I don’t want to put a bunch of chemicals in my body.”

Me:  “Do you take any meds at all?”

Susan:  “No way.  Like I said, I don’t want to put a bunch of chemicals in my body.”

Me:  “Do you take any supplements?”

Not surprisingly, Susan pulled a Ziploc bag out of her purse, filled with every supplement I’ve ever heard of, and some that I hadn’t.  I said, “Wow – that’s a lot of chemicals that you’re putting into your body.”  I grab a bottle at random and show it to her.  “What does the research say about this one?”

Susan:  “What do you mean?”

Me:  “Do people who take it live longer?  Which people?  Are you one of those people?  How can we tell?”

Susan:  * starting to get understandably defensive *
“Look, can we just repeat these labs, and see what we find?”

Me:  “Not if we’re not going to treat it.  If you’ve decided not to treat your heart disease, that’s fine.  That’s your prerogative.  But if we’re considering treatment, I think we should check some basic stuff, look for root causes of disease, and decide on a rational course of action here.”

Susan:  “What about my SDMA?  What about all those other inflammation markers?”

Me:  “Those may prove to be relevant someday, but right now they’re very poorly understood.  Let’s work with what we know – what we have evidence to support.  We already have what we need.  Let’s develop a plan of attack, based on your particular situation.  Find the disease.  Fix the disease.  Move on with our lives.  Checking the same meaningless tests over and over again is unhelpful.  And if that’s your plan of action, then you don’t need me.”

Well, things went downhill from there.

She wanted to do more tests, but didn’t want to treat.  I wanted to treat, but didn’t want to do more tests.  The only reason the conversation went on as long as it did was that her husband was there, and didn’t want to walk away from potentially life-saving treatment.

I found it fascinating that she was so unwilling to consider treatments, but she was so insistent on doing more and more testing.  Why do all these tests to find a problem that you have no interest in fixing?

Consider the global warming crowd.  They want more and more computer models.  Is the earth warming by 1.7 degrees?  Or is it 1.9 degrees?  Let’s do more studies!

Well, ok.  But if fossil fuels are dangerous, perhaps we might consider nuclear power, which results in only warm water and tiny amounts of nuclear waste which can be easily contained and managed.  Ok.  Let’s get to work.

No.  Let’s do more and more computer models.  Which we refuse to act on.

How many studies have been done on the problems of children of broken families, pipelines, welfare programs, ethanol fuel, virus mitigation strategies, immigration policies, and so on?  We keep doing more studies.  And more and more and more.

But it’s easier to study these things than to fix them.  So we search for problems that we fully intend to ignore.  This seems odd, but it is not unusual behavior.

Now, I understand, up to a point.  Our fears of statins, nuclear power, intact families, and so on prevent us from considering rational treatments, so we do more studies.  Got to spend that grant money somehow, right?  And maybe we might find a more palatable solution.  Maybe.

But what if we don’t?

It seems to me that sometimes the more data someone wants, the less interested they are in fixing the problem they’re studying.  Or something.

One problem here is probably that in order to improve most of our social problems, our government would need to do less, and spend less, rather than more.  No politician can run for office on that, so they avoid exploring solutions (which might not work, which would look bad) and they spend more money on studies.

But I don’t think that’s it, entirely.  I think there may be a parallel between excessive government studies and my patients who want every test under the sun run on them, regardless of the evidence behind these tests, because they want to “do something” about a disease they have no interest in treating.

“Susan’s” approach to heart disease seems similar to Nancy Pelosi’s approach to homelessness.  And is similarly effective.

Perhaps this isn’t just political expediency – perhaps it’s human nature.

Or perhaps it’s not.

What do you think?

Published in General
This post was promoted to the Main Feed by a Ricochet Editor at the recommendation of Ricochet members. Like this post? Want to comment? Join Ricochet’s community of conservatives and be part of the conversation. Join Ricochet for Free.

There are 124 comments.

Become a member to join the conversation. Or sign in if you're already a member.
  1. kedavis Coolidge
    kedavis
    @kedavis

    Henry Castaigne (View Comment):

    Dr. Bastiat (View Comment):

    Headedwest (View Comment):

    When I was going for my PhD, it was mandatory to attend the Friday afternoon seminars, where new research was presented, visitors presented their current research, and advanced PhD students presented their dissertation research. Often tangential discussions occurred.

    Some of our faculty were the people who taught statistics courses in the medical school at the the university hospital.

    They described teaching statistics to MD candidates as similar to trying to teach dogs how to use doorknobs.

    The difference, of course, is that dogs have at least a passing interest in doorknobs, and understand that they’re somehow important.

    Doctors tend to be lousy at stats. I’m not sure why. But it’s true.

    Stats are way less interesting than the person in front of you.

    But if the person in front of you is lousy at stats, could still be a problem.

    • #91
  2. OkieSailor Member
    OkieSailor
    @OkieSailor

    Dr. Bastiat: It seems to me that sometimes the more data someone wants, the less interested they are in fixing the problem they’re studying.  Or something.

    Caveat: I haven’t read all the comments, please excuse it if I am duplicating anything here ;>)

    I find that risk averse folks all have what I consider a basic flaw: they can’t come to a decision until they know absolutely every thing that might affect the outcome of a given action. Since it is impossible to ever have that complete knowledge beforehand they are stymied from taking action. While it’s better to ‘look before you leap’ being hamstrung in this way means forgoing both the risks and benefits of taking reasonable chances, and sometimes failing.

    I do apply this to our over reaction to the danger posed by Covid19 and believe it contributed directly to the tragic consequences of that over reaction which will be felt for years to come.

     

    • #92
  3. Old Bathos Member
    Old Bathos
    @OldBathos

    OkieSailor (View Comment):

    I find that risk averse folks all have what I consider a basic flaw: they can’t come to a decision until they know absolutely every thing that might affect the outcome of a given action. Since it is impossible to ever have that complete knowledge beforehand they are stymied from taking action. While it’s better to ‘look before you leap’ being hamstrung in this way means forgoing both the risks and benefits of taking reasonable chances, and sometimes failing.

    I do apply this to our over reaction to the danger posed by Covid19 and believe it contributed directly to the tragic consequences of that over reaction which will be felt for years to come.

    This is the George McClellan syndrome.  You have more than enough resources and information to take reasonably constructive action but get yourself in trouble by refusing to act with less than perfect information and instead take pointless, costly, self-defeating defensive postures only useful against imaginary threats.

    • #93
  4. Ed G. Member
    Ed G.
    @EdG

    There may have been a time when credentials carried weight as a general rule, but not anymore. 

    Cholesterol of my 30 year old self just over the line? Statins forever, apparently. Nuts to that. My 47 year old self never having taken the statins? No cholesterol problems. I chose wisely, I think. Certainly I chose more thriftily. 

    I’d love to be able to find a worthy doctor. Alas, the only one close is my wife’s ob/gyn, but those stirrups don’t fit.

    “Susan” may be fighting against what she doesn’t want to believe. Or, she may in fact be both smarter and more invested in her own care than the credentialed person she’s been consulting. I don’t  mean you, Doc, but in general. That’s all too real, and I’m coming to believe, the natural state.

    Good doctors, like good anything, are rare.

    • #94
  5. Doug Kimball Thatcher
    Doug Kimball
    @DougKimball

    The Reticulator (View Comment):

    Doug Kimball (View Comment):
    Levy is nonplussed and tries to explain. “As it was described to me, ‘Nature’ is a new kind of journal. The editors want to support serious scholarship, but they also want to make science as accessible as possible to the public. They want to be to the natural sciences what ‘Architectural Digest’ is to architecture.”

    You did realize that there is an actual peer-reviewed journal called Nature, and that it has been around a long time? I realize you were writing fiction, but that threw me.

    And when it’s time for tenure review, I would think scientists would get points for condescending to interact with the public in a popular journal. They won’t get tenure based on that, but these days they might lose points for not doing some sort of public outreach. Officially, anyway.

    I wrote this long ago when “Nature” was new and scoffed at by the scientific community as a “picture book.”

    • #95
  6. Bob Thompson Member
    Bob Thompson
    @BobThompson

    Ed G. (View Comment):
    Cholesterol of my 30 year old self just over the line? Statins forever, apparently. Nuts to that. My 47 year old self never having taken the statins? No cholesterol problems. I chose wisely, I think. Certainly I chose more thriftily. 

    I don’t recall the exact year I started on statins but let’s say 25 years ago. A few years back the numbers were looking really good but my new cardiologist, I just moved to AZ, went through a spiel about how coming off the statin could be more risky than continuing since I’ve never had any discernible side effects. So there, I’m still taking statins.

    • #96
  7. Arahant Member
    Arahant
    @Arahant

    Ed G. (View Comment):
    Alas, the only one close is my wife’s ob/gyn, but those stirrups don’t fit.

    🤣🤣🤣

    • #97
  8. HeavyWater Inactive
    HeavyWater
    @HeavyWater

    Bob Thompson (View Comment):

    Ed G. (View Comment):
    Cholesterol of my 30 year old self just over the line? Statins forever, apparently. Nuts to that. My 47 year old self never having taken the statins? No cholesterol problems. I chose wisely, I think. Certainly I chose more thriftily.

    I don’t recall the exact year I started on statins but let’s say 25 years ago. A few years back the numbers were looking really good but my new cardiologist, I just moved to AZ, went through a spiel about how coming off the statin could be more risky than continuing since I’ve never had any discernible side effects. So there, I’m still taking statins.

    I had a situation similar to Ed G’s earlier this year but regarding elevated blood pressure (hypertension).

    I drove to a doctor’s appointment during a snowstorm.  I climbed several flights of stairs to see the physician and my blood pressure was checked.  I won’t go into what the appointment was actually for, but it wasn’t for blood pressure.  My blood pressure had always been below 120/80.

    This time, though, my blood pressure was 151/86.  The physician didn’t say anything at the time.  But a day later I heard from a member of the physician’s staff.  She said that she, not the phyisican, raised an alarm about my blood pressure and convinced the physician to have me take a low dose anti-hypertensive until I could follow up with my primary care physician.

    I thought this was a clumsy way of diagnosing hypertension (high blood pressure), by taking a single blood pressure measurement in a high stress situation.  So, I told this staff member that I would just check my blood pressure every day until I saw my primary care physician and then let this primary care physician decide if my numbers looked good.

    I messaged my primary care physician and told him my plan, but he punted the issue back to the physician-specialist I had just seen, the one who wanted me to take the low dose hypertensive.

    So, I found a different primary care physician and set up an appointment.  This new doctor thought that blood pressure numbers were fine (they were consistently under 120/80).  I sent this information to the physician-specialist.  Everyone agreed that I didn’t need to take an anti-hypertensive.

    Geez.

    • #98
  9. Nanocelt TheContrarian Member
    Nanocelt TheContrarian
    @NanoceltTheContrarian

    Dr. Bastiat (View Comment):

    Arahant (View Comment):
    I suspect “Susan” would need statistics on statins, not that she’d necessarily understand them. And they probably wouldn’t change her mind.

    I gave her statistics on statins. Lots of very compelling statistics.

    And you’re right – it didn’t change her mind.

    Statins are the evil medicine de jour. I have less than a 50% success rate at even getting patients with Familial Heterozygous hypercholesterolemia to take them.  A recent paper showed that the reported side effects of statins in almost all patients are due to a nocebo effect–that is, a noxious placebo effect–in the perception of the patient but not otherwise reality based. They are one of the safest medicines ever discovered, and have contributed to the reduction of cardiovascular disease over the last 30 years or so. Still, we have supposed scientists writing books trashing statins as showing limited benefit, with very low absolute reduction of cardiovascular events vs relative reduction of events.  Vaccine deniers are almost insignificant compared to Statin deniers. And they have far better grounds for their dissent. 

    It is true that there has never been a really good large, sufficiently long term, sufficiently high dose statin study to establish beyond question the full absolute benefits vs risks of statins. And every patient I see has a friend or relative that supposedly has had severe side effects or injury from statins, and almost all patients are reluctant to take them, so potent are the internet “data” on statins. 

    Most of the patients that I talk in to trying ezetimibe in place of a statin, report exactly the same side effects from this medicine that they report from statins. Some even report the same side effects from Welchol. 

    The I offer PCSK-9 inhibitors to those who qualify for these (LDL around 200 or above). Then they completely freak out. Mostly. And it’s rare to get the prior auth through the insurance company anyway, particularly for someone who has not already had a heart attack. 

    All of that said, John Ionides, the epidemiologist from Stanford, notes that 95% or more of the medical literature is incorrectly analyzed statistically. So even the medical researches get it mostly wrong. And then there is the problem of politicization of medical journals. They have long been corrupt. Witness the article on vaccines causing autism–concocted, fraudulent data, and it took the Lancet more than a decade to retract the paper. 

    So, we have “evidenced-based” medicine, which is almost an oxymoron. Then we have “eminence-based” medicine, going by the recommendations of the gurus–a fraught approach indeed. Then we have “faith based” medicine, which, by default, is what most of us actually practice out here in the boondocks. 

    Statistics? Statistics? We don’t need no stinking’ statistics! (To borrow dialogue from The Treasure of the Sierra Madre). 

    I can give you  studies that, while statistically impressive, were completely bogus. 

    • #99
  10. Old Bathos Member
    Old Bathos
    @OldBathos

    Nanocelt TheContrarian (View Comment):

    Statistics? Statistics? We don’t need no stinking’ statistics! (To borrow dialogue from The Treasure of the Sierra Madre). 

    I can give you  studies that, while statistically impressive, were completely bogus. 

    • #100
  11. Flicker Coolidge
    Flicker
    @Flicker

    Has any doctor ever actually looked at Lipoprotein(a) as an indicator for heart disease, heart attack and stroke?

    • #101
  12. Dr. Bastiat Member
    Dr. Bastiat
    @drbastiat

    Flicker (View Comment):

    Has any doctor ever actually looked at Lipoprotein(a) as an indicator for heart disease, heart attack and stroke?

    Yep.  Important marker.

    • #102
  13. Henry Racette Member
    Henry Racette
    @HenryRacette

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Has any doctor ever actually looked at Lipoprotein(a) as an indicator for heart disease, heart attack and stroke?

    Yep. Important marker.

    This comment and response makes me think of my relationship to expertise.

    Doctors are presumably expert in their respective specialties, and broadly knowledgeable about matters of health. It’s probably unwise for most of us who aren’t doctors to assume that doctors don’t take doctoring seriously, that they make obvious and clumsy mistakes that even non-doctors can readily see. (Of course, if I keep hearing that doctors are numerically illiterate, I might have to revise that view.)

    I’ve never been on a movie set, and I don’t know what it’s like, the pressure and dynamic and roles and duties and responsibilities. I know a lot about guns — am even somewhat expert on the topic — and have strong opinions about guns, but that doesn’t include strong opinions about guns used as props on movie sets.

    I don’t know beans about philosophy, but somehow feel free to express criticism of the views of professional philosophers, as I did a few minutes ago on SA’s post about this Plantinga fellow. So I’m doing something there that I’d rarely consider doing regarding medicine or movie making.

    I suppose that means that I have a fair amount of respect for doctors (who knew?), and more respect for the people who make movies than for the people who write philosophy textbooks.

    Huh.

    • #103
  14. Flicker Coolidge
    Flicker
    @Flicker

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Has any doctor ever actually looked at Lipoprotein(a) as an indicator for heart disease, heart attack and stroke?

    Yep. Important marker.

    I’m surprised.  I’ve always had to ask for it for more than a decade now.  But they routinely do a lipid panel.

    • #104
  15. Dr. Bastiat Member
    Dr. Bastiat
    @drbastiat

    Flicker (View Comment):

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Has any doctor ever actually looked at Lipoprotein(a) as an indicator for heart disease, heart attack and stroke?

    Yep. Important marker.

    I’m surprised. I’ve always had to ask for it for more than a decade now. But they routinely do a lipid panel.

    Yeah, lots of docs ignore it.

    Remember, I’m a lipid geek.

    • #105
  16. Henry Castaigne Member
    Henry Castaigne
    @HenryCastaigne

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Has any doctor ever actually looked at Lipoprotein(a) as an indicator for heart disease, heart attack and stroke?

    Yep. Important marker.

    I’m surprised. I’ve always had to ask for it for more than a decade now. But they routinely do a lipid panel.

    Yeah, lots of docs ignore it.

    Remember, I’m a lipid geek.

    Lipid Geek was a garage punk band in Bristol were all the guys knew each other from fastfood work.

    • #106
  17. Flicker Coolidge
    Flicker
    @Flicker

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Has any doctor ever actually looked at Lipoprotein(a) as an indicator for heart disease, heart attack and stroke?

    Yep. Important marker.

    I’m surprised. I’ve always had to ask for it for more than a decade now. But they routinely do a lipid panel.

    Yeah, lots of docs ignore it.

    Remember, I’m a lipid geek.

    Not that there’s a point to this question, but do you routinely order it on an initial visit?  Or is it a follow-up test for specific symptoms or prior lab results?

    • #107
  18. Dr. Bastiat Member
    Dr. Bastiat
    @drbastiat

    Flicker (View Comment):

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Has any doctor ever actually looked at Lipoprotein(a) as an indicator for heart disease, heart attack and stroke?

    Yep. Important marker.

    I’m surprised. I’ve always had to ask for it for more than a decade now. But they routinely do a lipid panel.

    Yeah, lots of docs ignore it.

    Remember, I’m a lipid geek.

    Not that there’s a point to this question, but do you routinely order it on an initial visit? Or is it a follow-up test for specific symptoms or prior lab results?

    Depends on the situation.  Lots and lots and lots of variables…

    • #108
  19. Henry Castaigne Member
    Henry Castaigne
    @HenryCastaigne

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Has any doctor ever actually looked at Lipoprotein(a) as an indicator for heart disease, heart attack and stroke?

    Yep. Important marker.

    I’m surprised. I’ve always had to ask for it for more than a decade now. But they routinely do a lipid panel.

    Yeah, lots of docs ignore it.

    Remember, I’m a lipid geek.

    Not that there’s a point to this question, but do you routinely order it on an initial visit? Or is it a follow-up test for specific symptoms or prior lab results?

    Depends on the situation. Lots and lots and lots of variables…

    Lots of Variables was a Techno Band.

    • #109
  20. kedavis Coolidge
    kedavis
    @kedavis

    Henry Castaigne (View Comment):

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Has any doctor ever actually looked at Lipoprotein(a) as an indicator for heart disease, heart attack and stroke?

    Yep. Important marker.

    I’m surprised. I’ve always had to ask for it for more than a decade now. But they routinely do a lipid panel.

    Yeah, lots of docs ignore it.

    Remember, I’m a lipid geek.

    Not that there’s a point to this question, but do you routinely order it on an initial visit? Or is it a follow-up test for specific symptoms or prior lab results?

    Depends on the situation. Lots and lots and lots of variables…

    Lots of Variables was a Techno Band.

    and Confounding Variables was ska/punk.

    • #110
  21. Nanocelt TheContrarian Member
    Nanocelt TheContrarian
    @NanoceltTheContrarian

    Sandy (View Comment):

    It’s pretty confusing being a patient. For instance, I’ve read books by Dr. Malcolm Kendrick, whose specialty is heart disease and he loves statistics. Doctoring Data was the first book I read, and it was very helpful in understanding what is meant when research results are reported, and to learn that most physicians–or so Kendrick claims–do not understand the difference between relative and absolute percentages. But he has written two books arguing against the use of statins, and he bases his arguments on statistics that he tries to break down for us patients. So you can see my problem.

    Here is a little part of what he has to say on the question of how much longer one is likely to live if one takes statins, based, he says, on the Scandinavian Simvastatin Survival Study and the Heart Protection Study. This is from his blog.

    Statins do not prevent fatal heart attacks and strokes. They can only delay them. They delay them by about one or two days per year of treatment. For those who have read my books you will know that I have regularly suggested we get rid of the concept of ‘preventative medicine’. We need to replace it with the concept of ‘delayative medicine’.

    You cannot stop people dying. You can only make them live longer. How much longer is the key question. With statins this question has been answered. You can, to be generous, add a maximum of two days per year to life expectancy.

    Actually, the impact of statins is much better than this in patients with type 2 diabetes. Plus, cardiologist have an intrinsic conflict of interest, in that they are happy to do stunting to prevent/delay heart attacks. Before there were eluting stents, some 30 years ago, a study was published in the NEJM by cardiologists regarding patients with stable angina. The study consisted of doing treadmills on the patients to see how far they could go without chest pain. Then the patients were randomized to medical management vs angioplasty. After 6 months, the patients were studied again with treadmill stress tests, and the patients who had had angioplasty could go further on the treadmill than those on medical therapy. There was no difference in MI’s or other acute events. The conclusion was that stable angina should be managed by angioplasty. The problem was that the peak incidence of restenosis and acute myocardial infarction  after angioplasty occurred at 1 year. That was known at the time of the study. So the study was designed specifically to avoid the bad outcomes that occurred at 1 year. A completely dishonest study. But it established the care standard of performing angioplasties on stable angina. 

    That standard is now gone. 

    Further, cardiovascular surgeons used to tell patients that CABG would save their lives. It wasn’t true. The procedure was palliative, resolved angina, and didn’t prolong life at all, except in a small subset of the patients. 

    • #111
  22. Old Bathos Member
    Old Bathos
    @OldBathos

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Dr. Bastiat (View Comment):

    Flicker (View Comment):

    Has any doctor ever actually looked at Lipoprotein(a) as an indicator for heart disease, heart attack and stroke?

    Yep. Important marker.

    I’m surprised. I’ve always had to ask for it for more than a decade now. But they routinely do a lipid panel.

    Yeah, lots of docs ignore it.

    Remember, I’m a lipid geek.

    Not that there’s a point to this question, but do you routinely order it on an initial visit? Or is it a follow-up test for specific symptoms or prior lab results?

    Depends on the situation. Lots and lots and lots of variables…

    Cardiology seems like magic to me. Somebody once looked at squiggles on a tape that to me looked exactly like the squiggles in the picture of normal lines and squiggles on the internet. Sent me for further testing which was OK because the cardiologist was exceptionally good-looking. So, naturally, the one time I actually looked forward to extensive follow-up, it turned out to be nothing.

    • #112
  23. Randy Webster Inactive
    Randy Webster
    @RandyWebster

    Old Bathos (View Comment):
    Sent me for further testing which was OK because the cardiologist was exceptionally good-looking.

    I went in for liver tests a couple of times.  Both times, the very attractive PA wore low cut tops and spent a lot of time bending over.  I think she just wanted to give us old guys a thrill.

    • #113
  24. Arahant Member
    Arahant
    @Arahant

    Randy Webster (View Comment):

    Old Bathos (View Comment):
    Sent me for further testing which was OK because the cardiologist was exceptionally good-looking.

    I went in for liver tests a couple of times. Both times, the very attractive PA wore low cut tops and spent a lot of time bending over. I think she just wanted to give us old guys a thrill.

    Sounds like a heart and blood pressure test to me. 😆

    • #114
  25. Flicker Coolidge
    Flicker
    @Flicker

    Randy Webster (View Comment):

    Old Bathos (View Comment):
    Sent me for further testing which was OK because the cardiologist was exceptionally good-looking.

    I went in for liver tests a couple of times. Both times, the very attractive PA wore low cut tops and spent a lot of time bending over. I think she just wanted to give us old guys a thrill.

    Yeah, raise your levels.

    • #115
  26. Doug Kimball Thatcher
    Doug Kimball
    @DougKimball

    Doug Kimball (View Comment):

    I illustrated the anti-math, anti-statistics bias in my novel, “Acadia”. Here is the excerpt:

    Levy’s controversial calling was first introduced when an excerpt of his doctoral thesis at Columbia was published in the nascent “Nature” journal and picked up by all of the news agencies as well as Newsweek and Time. The title of the popular article, ‘Your Chihuahua is a Wolf,’ explains that according to Levy’s research, the genetic code of a Chihuahua varies by less than an estimated 0.3% from that of a wild Gray Wolf, and that this variation is smaller than the variation between an Aboriginal Australian and a typical American of any race. Of course, the point of Levy’s paper is to illustrate revolutionary techniques for mapping and sequencing genetic material using advances in micro-optics, biochemistry, mathematics and complex population trait statistics. These statistics were developed after the years of continued cross breeding of dogs with wolves and then following the occurrence of traits unique to each variant. The science itself is lost on the editor from “Nature” who instead is intrigued by the obvious fact that a single species could produce such wide physical variation. Among Levy’s colleagues, this popular media attention labels him a “junk” scientist. This potent combination of ignorance, jealousy and envy eventually precluded Levy from receiving an offer of tenure at Columbia.

    Levy remembers the precise moment of his rejection. The Columbia Biology (which at the time included both Zoology and Botany) Department chair, Arnold Silverstein, a churlish little man, had called him in for “a special counseling meeting.” Levy naively thought that this would be a cordial meeting, perhaps to discuss his new lab program for the pre-med undergraduate course requirement, Bio-5. He was quite proud of this program, an extension of his other work which involved the study of drosophila – fruit flies. They are cross-bred over several generations and statistics related to the occurrence of debilitating recessive traits allowed some rudimentary genetic modeling. But Silverstein does not want to talk about fruit flies. He asks Levy to sit in one of the low, upholstered chairs at a small round, marble-topped, table crowded next to the chairman’s immense cherry desk. As soon as Levy is comfortably seated, Silverstein tosses a copy of ‘Nature’ on the table and asks, “What’s this?”

    “It’s ‘Nature’,” Levy says, “a popular science journal.”

    “Don’t get smart with me, Levy. I mean, since when do Columbia scholars have their papers published in magazines like this?”

    “I’m not sure I understand your question. I didn’t publish anything in “Nature” per se. They referred to my research in an article. The article is loosely about my work, but it is not my work.”

    “Referred to your research? They referred to your research here at Columbia?” Silverstein gets up from his chair and begins pacing.

    Levy is nonplussed and tries to explain. “As it was described to me, ‘Nature’ is a new kind of journal. The editors want to support serious scholarship, but they also want to make science as accessible as possible to the public. They want to be to the natural sciences what ‘Architectural Digest’ is to architecture.”

    “A serious scientific journal does not publish ‘Your Chihuahua is a Wolf’.” Silverstein stops and turns his head to avoid Levy’s attempt at eye contact.

    “I didn’t pick the title. I guess ‘Nominal Statistical Genetic Diversity Among Indigenous North American Canines’ is not a title the editor felt would encourage readership.” Levy remains proud that his research was the basis for an article in this slick new journal.

    Silverstein starts to pace again and does not immediately react to Levy’s remark. When he does react, he chooses to return the sarcasm. “Why didn’t you just send the paper to ‘Popular Science’? I’m sure some of the editors there like dogs.”

    Levy does not know how to react, so picks up the journal. He immediately notices that it is in perfect condition, right off the press, not a dog-ear, not a bend of a page, not a bit of evidence that it was ever opened. Finally, in self-defense, he breaks the silence. “Did you read the article? Did you even look through the magazine?”

    “I read serious scholarship, Mr. Levy. I don’t have time for magazines.” Silverstein squints at Levy, plants both hands firmly on the small table and pulls, looking even more rat-like than usual, closer to Levy. “At Columbia in my Biology Department we don’t like to be embarrassed. We take our science seriously. Our relationship to our work is visceral – we dissect, we describe, we experiment, we explore. The statisticians and mathematicians are over in Cable Hall in the Physics and Math departments. That’s where they belong. And we don’t publish our work in popular science magazines. Do I make myself clear?”

    Available at Barnes and Noble!

    • #116
  27. Headedwest Coolidge
    Headedwest
    @Headedwest

    Way up in the early part of this comment thread, I recounted a story of the frustration of the faculty members who were teaching the statistics course to MDs at the university where I eventually got my PhD.

    It was sort of a slam on doctors, and I want to make the point that I really appreciate MDs like Dr. Bastiat who work on understanding statistics. I studied (and taught) statistics for years before I fully understood how subtle and elusive a process it is. If you are truly interested in the mysteries of statistics, and willing to spend money and time for that knowledge, I recommend the book Uncertainty: The Soul of Modeling, Probability and Statistics by William Briggs. The book is not for the faint hearted, but it is amazingly perceptive. Briggs wants to revolutionize statistics, and he has the analytical chops to make his case.

    What we have now are software packages that make it trivially easy to run a statistical test, but are of no help at all of telling you whether or not the test is useful or whether a perceived difference is important. And powerful stats software combined with data collection and massive databases make it trivially easy to to do bogus studies by just plowing through data and tests until you get a result that crosses the magical P<0.05 threshold that makes it publishable.

    This has become such a serious problem in medical research that there are serious efforts to replace the standard criteria for significance with new ways of showing that a result matters. But there is no consensus on how that will work out.

    What I tell anybody who asks is that when you read a “popular” news story with the headline or the lead sentence “Studies have shown ….”  you might as well skip to the next thing to read.

    Anyway, kudos to Dr. Bastiat for his work to understand complex processes to make life better for his patients.

    • #117
  28. MarciN Member
    MarciN
    @MarciN

    Randy Webster (View Comment):

    Old Bathos (View Comment):
    Sent me for further testing which was OK because the cardiologist was exceptionally good-looking.

    I went in for liver tests a couple of times. Both times, the very attractive PA wore low cut tops and spent a lot of time bending over. I think she just wanted to give us old guys a thrill.

    In a book I read years ago, I came across a story about a student in medical school who created a video on how to do CPR. He wanted it to be viewed by the general public as much as possible. So he called it “French Maids.” :-) :-)

    • #118
  29. The Reticulator Member
    The Reticulator
    @TheReticulator

    Headedwest (View Comment):
    And powerful stats software combined with data collection and massive databases make it trivially easy to to do bogus studies by just plowing through data and tests until you get a result that crosses the magical P<0.05 threshold that makes it publishable.

    That really shouldn’t get past the reviewers, though.   I knew a sociology professor who ran a diploma mill for masters level teacher students going for their salary increment, who advised his students to do exactly what you describe when it came to analyzing survey questionnaire responses.  When I tried to suggest, very carefully, that it wasn’t quite kosher to do those multiple comparisons without making adjustments, he played dumb.  Well, those theses weren’t going to get published anywhere, but I would disappointed in a medical journal that would let something like that slide by.  

    • #119
  30. Headedwest Coolidge
    Headedwest
    @Headedwest

    The Reticulator (View Comment):
    That really shouldn’t get past the reviewers, though.

    Unfortunately it does. The case of Brian Wansink at Cornell tells you all you need to know.

    • #120
Become a member to join the conversation. Or sign in if you're already a member.